活性氧
炎症
化学
巨噬细胞极化
材料科学
药理学
巨噬细胞
细胞生物学
体外
免疫学
生物化学
医学
生物
作者
Jonghoon Kim,Han Young Kim,Seuk Young Song,Seok-hyeong Go,Hee Su Sohn,Seungmin Baik,Min Soh,Kang Kim,Dokyoon Kim,Hyo‐Cheol Kim,Nohyun Lee,Byung‐Soo Kim,Taeghwan Hyeon
出处
期刊:ACS Nano
[American Chemical Society]
日期:2019-03-04
卷期号:13 (3): 3206-3217
被引量:561
标识
DOI:10.1021/acsnano.8b08785
摘要
Poor O 2 supply to the infiltrated immune cells in the joint synovium of rheumatoid arthritis (RA) up-regulates hypoxia-inducible factor (HIF-1α) expression and induces reactive oxygen species (ROS) generation, both of which exacerbate synovial inflammation. Synovial inflammation in RA can be resolved by eliminating pro-inflammatory M1 macrophages and inducing anti-inflammatory M2 macrophages. Because hypoxia and ROS in the RA synovium play a crucial role in the induction of M1 macrophages and reduction of M2 macrophages, herein, we develop manganese ferrite and ceria nanoparticle-anchored mesoporous silica nanoparticles (MFC-MSNs) that can synergistically scavenge ROS and produce O 2 for reducing M1 macrophage levels and inducing M2 macrophages for RA treatment. MFC-MSNs exhibit a synergistic effect on O 2 generation and ROS scavenging that is attributed to the complementary reaction of ceria nanoparticles (NPs) that can scavenge intermediate hydroxyl radicals generated by manganese ferrite NPs in the process of O 2 generation during the Fenton reaction, leading to the efficient polarization of M1 to M2 macrophages both in vitro and in vivo . Intra-articular administration of MFC-MSNs to rat RA models alleviated hypoxia, inflammation, and pathological features in the joint. Furthermore, MSNs were used as a drug-delivery vehicle, releasing the anti-rheumatic drug methotrexate in a sustained manner to augment the therapeutic effect of MFC-MSNs. This study highlights the therapeutic potential of MFC-MSNs that simultaneously generate O 2 and scavenge ROS, subsequently driving inflammatory macrophages to the anti-inflammatory subtype for RA treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI